Succesful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension

Liver Transplantation

Volumn 12, Issue 3, 2006, Pages 481-484

  Uchiyama, Hideaki ^a   Soejima, Yuji ^b   Taketomi, Akinobu ^a   Yoshizumi, Tomoharu ^a   Harada, Noboru ^a   Ijichi, Hideki ^a   Yonemura, Yusuke ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTACYCLIN; STEROID; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; DAUGHTER; DISEASE SEVERITY; FEMALE; GENERAL CONDITION IMPROVEMENT; HEART CATHETERIZATION; HEPATITIS C; HOSPITAL DISCHARGE; HUMAN; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG ARTERY PRESSURE; ORGAN DONOR; OUTPATIENT CARE; PORTAL HYPERTENSION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT OUTCOME; CRITICAL ILLNESS; FOLLOW UP; GRAFT SURVIVAL; HEMODYNAMICS; LIVER FUNCTION TEST; LUNG FUNCTION TEST; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; RARE DISEASE; RISK ASSESSMENT;

ANTIHYPERTENSIVE AGENTS; CRITICAL ILLNESS; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; RARE DISEASES; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT;

EID: 33645289678     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20691     Document Type: Article

References (18)

1. Kuo PC, Plotkin JS, Johnson LB, Howell CD, Laurin JM, Bartlett ST, Rubin LJ. Distinctive clinical features of portopulmonary hypertension. Chest 1997; 112:980-986.
2. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000;6:443-450.
3. Kuo PC, Plotkin JS, Gaine S, Shroeder RA, Rustgi VK, Rubin LJ, Johnson LB. Portopulmonary hypertension and the liver transplant candidate. Transplantation 1999;67: 1087-1093.
4. Tan HP, Markowitz JS, Montgomery RA, Merritt WT, Klein AS, Thuluvath PJ, et a]. Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol. Liver Transpl 2001;7:745-749.
5. Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia. C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the Multicenter Liver Transplant Database. Liver Transpl 2004; 10: 174-182.
6. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004;363:1461-1468.
7. Plotkin JS, Kuo PC, Rubin LJ, Gaine S, Howell CD, Laurin J, et al. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 1998;65:457-459.
8. Miyamoto A, Kato T, Dono K, Umeshita K, Kawabata R, Hayashi S, et al. Living-related liver transplantation with renoportal anastomosis for a patient with large spontaneous splenorenal collateral. Transplantation 2003;75:1596-1598.
9. Mair P, Kaehler CH, Pomaroli A, Schwanz B, Vogel W, Margreiter R. Orthotopic liver transplantation in a patient with severe portopulmonary hypertension. Acta Anaesthesiol Scand 2001;45:513-518.
10. Starkel P, Vera A, Gunson B, Mutimer D. Outcome of liver transplantation for patients with pulmonary hypertension. Liver Transpl. 2002;8:382-388.
11. Ramsay MA, Schmidt A, Hein HA, Nguyen AT, Lynch K, East CA, et al. Nitric oxide does not reverse pulmonary hypertension associated with end-stage liver disease: a preliminary report. Hepatology 1997;25:524-527.
12. Olschewski H, Simonneau G, Galie N, Higenbottain T, Naeije R, Rubin LJ, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002;347:322-329.
13. Channick PN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study. Lancet 2001;358:1119-1123.
14. Scott V, De Wolf A, Kang Y, Martin M, Selby R, Fung J, et al. Reversibility of pulmonary hypertension after liver transplantation: a case report. Transplant Proc 1993;25: 1789-1790.
15. Koneru B, Ahmed S, Weisse AB, Grant GP, McKim KA. Resolution of pulmonary hypertension of cirrhosis after liver transplantation. Transplantation 1994;58:1133-1135.
16. Losay J, Piot D, Bougaran J, Ozier Y, Devictor D, Houssin D, Bernard O. Early liver transplantation is crucial in children with liver disease and pulmonary hypertension. J Hepatol 1998;28:337-342.
17. Prager MC, Cauldwell CA, Ascher NL, Roberts JP, Wolfe CL. Pulmonary hypertension associated with liver disease is not reversible after liver transplantation. Anesthesiology 1992;77:375-378.
18. Soejima Y, Shimada M, Suehiro T, Hiroshige S, Ninomiya M, Shiotani S, et al. Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl 2003;9:581-586.